Biodesix Inc (BDSX)
1.57
0.00 (0.00%)
USD |
NASDAQ |
May 21, 16:00
1.57
0.00 (0.00%)
After-Hours: 18:19
Biodesix Profit Margin (Quarterly): -91.87% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -91.87% |
| December 31, 2023 | -62.31% |
| September 30, 2023 | -81.16% |
| June 30, 2023 | -112.5% |
| March 31, 2023 | -206.5% |
| December 31, 2022 | -211.7% |
| September 30, 2022 | -123.3% |
| June 30, 2022 | -144.5% |
| March 31, 2022 | -238.0% |
| December 31, 2021 | -183.9% |
| Date | Value |
|---|---|
| September 30, 2021 | -176.3% |
| June 30, 2021 | -95.94% |
| March 31, 2021 | -24.11% |
| December 31, 2020 | -16.77% |
| September 30, 2020 | -96.21% |
| June 30, 2020 | -195.0% |
| March 31, 2020 | -190.4% |
| December 31, 2019 | -78.89% |
| September 30, 2019 | -243.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-243.6%
Minimum
Sep 2019
-16.77%
Maximum
Dec 2020
-135.4%
Average
-123.3%
Median
Sep 2022
Profit Margin (Quarterly) Benchmarks
| Fonar Corp | 7.28% |
| XWELL Inc | -28.79% |
| ProPhase Labs Inc | -172.4% |
| Applied DNA Sciences Inc | -480.9% |
| Veracyte Inc | -1.92% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -54.53% |
| Return on Invested Capital | -167.0% |
| Gross Profit Margin (Quarterly) | 78.57% |
| Operating Margin (Quarterly) | -73.92% |
| Return on Net Operating Assets | -86.05% |